[Clinical application and experimental studies of the pulsed inhaled nitric oxide flow controlling instrument].
A flow controlling system for pulsed inhaled nitric oxide has been developed and tested, and here its features and initial animal experiments and clinical applications are described. The physical characteristic test indicates that the practical released dose of NO gas is very close to the theoretical flow of NO gas at variant pressures. Animal experiments demonstrate that inhaled NO gas concentration is lower than the concentration of theoretical inhalation, but the variance is not remarkable (p>0.05). When sixteen cases with CHD and PH were chosen to inhale NO gas (15 ppm, 15 min) PAP and PVR of all cases were reduced after inhalation of NO gas from 617 +/-51.3 dyn x s x cm(-5), 54.4+/-13.1 mmHg to 417+/-36.9 dym x s x cm(-5), 33.8+/-12.3 mmHg (PVR, p<0.01; PAP, p<0.01) respectively. When gas inhalation was stopped, these values returned to their base lines after a short period of time. All these show that the pulsed inhaled NO flow controlling instrument in accordance with the requirements of the designing, can be widely used in clinical diagnoses and treatments and will be a new tool offered for the treatments of the patients with PH.
Mo
Xu-ming
XM
Nanjing Children's Hospital, Nanjing Medical University.
Zhao
En-chun
EC
Wang
Min-sheng
MS
Gu
Xinglin
X
Wang
Zhenxi
Z
Wang
Chunsheng
C
D000280:Administration, Inhalation; D000818:Animals; D001794:Blood Pressure; D002302:Cardiac Output; D002648:Child; D004867:Equipment Design / Q000295:instrumentation; D005260:Female; D006330:Heart Defects, Congenital / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D009330:Nebulizers and Vaporizers; D009569:Nitric Oxide / Q000008:administration & dosage* / Q000032:analysis; D011817:Rabbits; D014655:Vascular Resistance
D009569:Nitric Oxide